These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
875 related articles for article (PubMed ID: 32126149)
1. METTL3/YTHDF2 m Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149 [TBL] [Abstract][Full Text] [Related]
2. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495 [TBL] [Abstract][Full Text] [Related]
3. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS. Chen JX; Chen DM; Wang D; Xiao Y; Zhu S; Xu XL Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960869 [TBL] [Abstract][Full Text] [Related]
4. The m Cheng M; Sheng L; Gao Q; Xiong Q; Zhang H; Wu M; Liang Y; Zhu F; Zhang Y; Zhang X; Yuan Q; Li Y Oncogene; 2019 May; 38(19):3667-3680. PubMed ID: 30659266 [TBL] [Abstract][Full Text] [Related]
5. METTL3/YTHDF1 m Zhi D; Zhou K; Liu S; Yu W; Dong M; Yan C Pathol Res Pract; 2024 Jan; 253():155047. PubMed ID: 38154356 [TBL] [Abstract][Full Text] [Related]
6. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881 [TBL] [Abstract][Full Text] [Related]
7. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798 [TBL] [Abstract][Full Text] [Related]
8. METTL3 facilitates tumor progression via an m Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592 [TBL] [Abstract][Full Text] [Related]
9. METTL3-dependent N Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825 [TBL] [Abstract][Full Text] [Related]
10. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306 [TBL] [Abstract][Full Text] [Related]
11. N Jin H; Ying X; Que B; Wang X; Chao Y; Zhang H; Yuan Z; Qi D; Lin S; Min W; Yang M; Ji W EBioMedicine; 2019 Sep; 47():195-207. PubMed ID: 31409574 [TBL] [Abstract][Full Text] [Related]
12. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955 [No Abstract] [Full Text] [Related]
13. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer. Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396 [TBL] [Abstract][Full Text] [Related]
14. Dynamic m Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352 [TBL] [Abstract][Full Text] [Related]
15. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270 [TBL] [Abstract][Full Text] [Related]
16. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940 [TBL] [Abstract][Full Text] [Related]
17. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471 [TBL] [Abstract][Full Text] [Related]
18. The m Qin Y; Qiao Y; Li L; Luo E; Wang D; Yao Y; Tang C; Yan G Life Sci; 2021 Jun; 274():119366. PubMed ID: 33741419 [TBL] [Abstract][Full Text] [Related]
19. METTL3-mediated N Zang Y; Tian Z; Wang D; Li Y; Zhang W; Ma C; Liao Z; Gao W; Qian L; Xu X; Jia J; Liu Z Oncogene; 2024 Jul; 43(30):2338-2354. PubMed ID: 38879589 [TBL] [Abstract][Full Text] [Related]
20. m Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]